Science

Tehran and Moscow inked a deal whereby Iran’s Sobhan Recombinant Protein firm and Russia’s Petrovax company will jointly produce the Russian-developed 'Grippol Plus' flu vaccine in Iran, Petrovax President Yelena Arhangelskaya told Sputnik on Sunday. "We made the first delivery of 'Grippol Plus' to Iran in 2015 and got positive …

The modelling study, led by Dr. Marco Springmann from the Oxford Martin Programme on the Future of Food at the University of Oxford, UK, is the first of its kind to assess the impact of climate change on diet composition and bodyweight, and to estimate the number of deaths they …

Walter and Eliza Hall Institute researchers have uncovered a protein that is key to the development of blood cancers caused by a common genetic error. The discovery will help find future strategies for early treatment or possibly even prevention of these cancers. Seventy percent of human cancers have abnormally high …

Published on Friday in the New England Journal of Medicine, the LEAP-On study followed on from the LEAP (Learning Early About Peanut Allergy) study, both led by Professor Gideon Lack at King's College London, which found that the majority of infants at high-risk of developing peanut allergy are protected from …